Results of the Echelon-1 Trial New chemotherapy is a combination of brentuximab vedotin, and AVD - 101931

Spotlight
Video

Results of the Echelon-1 Trial New chemotherapy is a combination of brentuximab vedotin, and AVD

ASHReport has 256 videos Subscribe Here

Loading........
Description: Joseph M. Connors, MD from British Colombia Cancer Agency discusses results of the Echelon-1 Trial and new chemotherapy that is a combination of brentuximab vedotin, and AVD at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/11/18
Added : 9 months ago
Category : Hodgkin Lymphoma